HOME >> MEDICINE >> NEWS
Unique results from Swedish study of HIV vaccine

A Swedish HIV vaccine study conducted by researchers at Karolinska Institutet (KI), Karolinska University Hospital and the Swedish Institute for Infectious Disease Control (SMI) has produced surprisingly good results. Over 90 per cent of the subjects in the phase 1 trials developed an immune response to HIV. "Never has such a good result been seen with a vaccine of this type," says Professor Eric Sandstrm, Chief Physician at Karolinska University Hospital.

A vaccine developed by SMI scientists has now undergone the first clinical study on healthy individuals in Sweden in order to examine its safety and different methods of administration. The vaccine is what is known as a genetic vaccine, which uses parts of the virus DNA to stimulate the rapid endogenous production of the proteins for which the injected DNA codes.

The trial subjects were vaccinated on three occasions with this vaccine using a needle-free method of injection. In order to enhance the effect, the researchers also gave the subjects a fourth dose of a vaccine in which parts of the HIV virus DNA had been integrated into another virus (vaccinia = the cowpox virus). This vaccine-based HIV vaccine is produced by the USA's National Institutes of Health and was donated for use in this Swedish study.

"Our vaccine is designed in such a way that it's able to protect against many of the circulating HIV types in Africa and the West," says Professor Britta Wahren at the SMI/KI.

Over 90 per cent of the trial subjects developed an immune response to HIV, and the vaccines have been tolerated well.

Data from the study will be presented at the four-day HIV vaccine conference in Amsterdam starting 29 August under the heading "Multigene, multiclade HIV-1 plasmid DNA prime and MVA boost is safe and highly immunogenic in healthy human volunteers".

Scientists now hope to follow up the Swedish study with a larger phase 1 phase 2 study in Tanzania, planned to com
'"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
30-Aug-2006


Page: 1 2

Related medicine news :

1. Unique laboratory could make pavements more user-friendly
2. No butts about it: Unique UH database shows Texas is crushing out smoking
3. Unique vascular dysfunction in womens heart disease described in major journal supplement
4. Stem cell transplantation procedure results in long-term survival for amyloidosis patients
5. GSKs Pazopanib shows positive results in patients with advanced renal cell carcinoma
6. GSKs Pazopanib shows positive results in patients with advanced RCC and ovarian cancer
7. Targeted, oral agent Enzastaurin shows favorable results
8. Childhood obesity intervention shows promising results
9. Alpharma presents positive pharmacokinetic study results
10. UCSF brain tumor vaccine trial shows promising results
11. The eyes have it -- Autism research yields surprising results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... After many months of preparation, the providers ... Phoenix, Arcadia Allergy & Asthma. This new allergy and asthma clinic is conveniently located ... one stop destination for any immunological and respiratory medical care needs. , In the ...
(Date:1/14/2019)... ... January 15, 2019 , ... Early bird pricing for Medical Device ... management is just plain hard, complicated, conflicted, confusing. And it is getting even more ... are not intended as “major”, the new standard adds new definitions, changes the clause ...
(Date:1/14/2019)... ... ... Reviewed & Approved Living Well Providers of 2019. , Acupuncture, Dr. Wai ... - Maplewood , Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - ... Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - ...
(Date:1/13/2019)... (PRWEB) , ... January 12, 2019 , ... ... Professionals Committee (YPC) in conjunction with Temple University hosted a continuing education (CEU) ... and Mentees. The event aimed to create a series of talks to ...
(Date:1/11/2019)... MINNEAPOLIS (PRWEB) , ... January 11, 2019 , ... ... announced the three finalist teams in its “Next Generation Captive Insurance Solutions for ... by Strategic Risk Solutions. , The three finalist teams are: , ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... ... January 10, 2019 , ... Pelican BioThermal , ... rapidly expand under the leadership of Dominic Hyde, vice president of Credo™ on ... temperature controlled shipper rental program allowing organizations to choose the shipper application that ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... as a kind of partnership. The implicit terms of this partnership hold that ... and administer the most effective treatment to restore the patient to improved health. ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... announced today that Philips, the leading international health technology company, has taken a ... Additional investors include StartUp Health and NueCura Partners. , Babyscripts has spent the ...
Breaking Medicine Technology:
Cached News: